Skip to main content

Table 1 Sample characteristics.

From: CALHM1 P86L Polymorphism Modulates CSF Aβ Levels in Cognitively Healthy Individuals at Risk for Alzheimer’s Disease

 

Cognitively healthy

AD

 

Female

Male

Female

Male

Number of patients

34

12

141

62

CALHM1 rs2986017 C/C

16

5

73

35

CALHM1 rs2986017 C/T

15

6

62

22

CALHM1 rs2986017 T/T

3

1

6

5

APOE ε2/3

4

2

NDa

ND

APOE °2/4

1

0

ND

ND

APOE °3/3

16

6

ND

ND

APOE °3/4

11

4

ND

ND

APOE °4/4

2

0

ND

ND

Age at sample (average)

62.9

64.3

73.4

70.4

MMSE (± SDb)

29.8 (± 0.5)

29.8 (± 0.4)

21.1 (± 5.6)

22.7 (± 5.0)

Aβ 1–40 pg/mL (average ± SD)

8732 ± 3568

8696 ± 3816

ND

ND

Aβ 1–42 pg/mL (average ± SD)

381 ± 196

336 ± 177

475 ± 221

518 ± 278

  1. aND: not determined.
  2. bSD: standard deviation.